▁at ▁con ferences , ▁and ▁payment ▁for ▁articles ▁g host written ▁by ▁the ▁company ▁and ▁placed ▁by ▁phys icians ▁in ▁medical ▁journ als . ▁The ▁company ▁set ▁up ▁a ▁g host writing ▁programme ▁called ▁C AS P PER , ▁initially ▁to ▁produce ▁articles ▁about ▁P ax il ▁but ▁which ▁was ▁extended ▁to ▁cover ▁Av and ia . ▁ ▁As ▁part ▁of ▁the ▁settlement ▁G SK ▁signed ▁a ▁five - year ▁corpor ate ▁integrity ▁agreement ▁with ▁the ▁Department ▁of ▁Health ▁and ▁Human ▁Services , ▁which ▁obliged ▁the ▁company ▁to ▁make ▁major ▁changes ▁in ▁the ▁way ▁it ▁did ▁business , ▁including ▁changing ▁its ▁compens ation ▁program mes ▁for ▁its ▁sales ▁force ▁and ▁execut ives , ▁and ▁to ▁implement ▁and ▁maintain ▁trans par ency ▁in ▁its ▁research ▁practices ▁and ▁publication ▁policies . ▁It ▁announced ▁in ▁ 2 0 1 3 , ▁that ▁it ▁would ▁no ▁longer ▁pay ▁do ctors ▁to ▁promote ▁its ▁dru gs ▁or ▁attend ▁medical ▁con ferences , ▁and ▁that ▁its ▁sales ▁staff ▁would ▁no ▁longer ▁have ▁pres cription ▁targets . ▁ ▁Ros ig lit az one ▁( Av and ia ) ▁ ▁The ▁ 2 0 1 2 ▁settlement ▁included ▁a ▁criminal ▁fine ▁of ▁US $ 2 4 2 , 6 1 2 , 8 0 0 ▁for ▁failing ▁to ▁report ▁safety ▁data ▁to ▁the ▁F DA ▁about ▁Av and ia ▁( ros ig lit az one ), ▁a ▁di ab etes ▁drug ▁approved ▁in ▁ 1 9 9 9 , ▁and ▁a ▁civil ▁settlement ▁of ▁US $ 6 5 7 mill ion